Algemeen Ziekenhuis Delta — Clinical Trial Site

271 Registered trials

120 Currently recruiting

Organisation

Algemeen Ziekenhuis Delta

Location

Roeselare, Belgium

Identifier

ORG-100030725

Address

Sint-Rembertlaan 21, 8820, Belgium

Departments

#1005: Cardiology
#2002: Nephrology
#2053: Oncologie
#3101: Hematology
0501:Department of Pulmonary Diseas
0503 Urology
0503: Department of Pulmonary Disease
0508
1054: Department of Nuclear Medicine
1201; Nephrology
1603: Medische oncologie-hematologie
2201: Hematology
3001: Hematology
3003: Neurology
304: Gastrenterology
4203 : Pneumology
4301: Nefrology
7116: Hartziekten
Afd. Inwendige - hematologie
Anaesthesia & intensive care
Anesthesiology and Intensive Care Unit
AZ Delta - Campus Rumbeke
AZ Delta Campus Rumbeke
AZ-Delta
BE018A: Medische oncologie-hematologie
Cardio-Hartziekten
Cardiologie
Cardiology
CTC MDL
Departement of Hematology
Department of Gastroenterology/Hepatology
Department of Hematology
Department of Nephrology
Department of Pediatrics
Department of respiratory diseases
Department of Surgery
Dermatology
Dienst Maag/Darm/Lever
Digestieve Oncologie
Digestive oncologie
Digestive Oncology
Ear-Nose-Throat (ENT)
Endocrinologie
Endocrinologie - diabetes
Endocrinology
Gastro-enterology
Gastroenterology
Gastroenterology and Hepatology
Gastroenterology/Hepatology
Hematologie
hematology
Hematology Department
Hematology Dept
Intensive care
Intensive Care Medicine
Intensive care unit
Longziekten
Maag-, Darm- en leverziekten
Maag-darm-leverziekten
Medical Oncology
N/A
NA
Nephrologie
Nephrology
Neurologie
Neurology
Nierziekten-dialyse
Oncology
Pijnkliniek
Pneumolgy
Pneumologie
Pneumology
Pneumology Department
Pneumology Thoracic Oncology
Pneumonology
Pulmonary Physician and Thoracic Oncologist
Pulmonology
Pulmonology and Respiratory Oncology
Pulmonology, Oncology
Radiation Oncology
Radiotherapy
Radiotherapy-Oncology
Respiratory oncology
Rheumatology
Treatment centre
Urology

Clinical trials at this site (271)

Search interface

ZENITH: Zilebesiran in Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk … Recruiting

2025-522960-34-00 Established cardiovascular disease 5 2026-02-09
GRAALL 2024 - A 3-cohort Randomized Study evaluating the role of New Immunotherapeutic Agents and of Allogeneic Hematopoietic Stem Cell Tran… Recruiting

2024-511437-35-00 Patients aged 18-65 years old with newly diagnosed prev 10 2026-01-05
Atacicept in Multiple Glomerular Diseases Recruiting

2024-518465-10-00 Multiple Autoimmune Glomerular Diseases 4 2025-12-12
Phase II RAINSPOT: a multicentric open label trial of Zolbetuximab-Paclitaxel-Ramucirumab in second line setting for CLDN18.2 positive gast… Recruiting

2025-521358-41-00 CLDN18.2 positive gastro-esophageal adenocarcinoma 4 2025-12-11
A study to evaluate the impact on metastases-free survival with the addition of saruparib vs placebo to a standard radiotherapy androgen dep… Recruiting

2024-513586-39-00 Prostate Cancer 5 2025-12-10
A Phase 3, Randomized, Open-label, Multicenter Study Evaluating the Efficacy and Safety of TAR-210 Erdafitinib Intravesical Delivery System … Recruiting

2024-519493-39-00 High-risk Non-muscle-invasive Bladder Cancer with Susce 5 2025-12-09
Study to Evaluate Plozasiran in Adults with Hypertriglyceridemia (SHASTA-10 Study) Recruiting

2024-519712-13-00 Hypertriglyceridemia (HTG) 5 2025-12-08
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis Recruiting

2025-521242-26-00 Moderately to Severely Active Ulcerative Colitis 4 2025-11-27
A Study of BMS-986504 in Combination with Pembrolizumab Plus Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line M… Recruiting

2025-521511-40-00 metastatic non-small cell lung cancer 10 2025-11-18
TRITON-CM: A Study to Evaluate Nucresiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy Recruiting

2024-519917-72-00 Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amy 5 2025-10-29
Increasing the dosing interval of osimertinib in patients with EGFR mutated locally advanced or meta-static non-small cell lung cancer - OSI… Recruiting

2024-514693-47-01 EGFR mutated locally advanced or metastatic non-small c 11 2025-10-28
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin i… Recruiting

2024-518365-10-00 Previously Untreated Advanced or Metastatic Non-Squamou 5 2025-10-28
A study to evaluate dosing schedules of mirvetuximab soravtansine in patients with epithelial ovarian, primary peritoneal, or fallopian tube… Recruiting

2024-517184-23-00 platinum-resistant advanced high-grade epithelial ovari 4 2025-10-16
EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure… Recruiting

2025-521188-11-00 Type 2 diabetes 5 2025-10-15
Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Platinum Resistant Ovarian Cancer Recruiting

2024-514822-21-00 Platinum-resistant Ovarian Cancer 5 2025-10-02
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-line Treatment of PD-L1-high Metastatic Non-small Cell Lung… Recruiting

2024-517780-24-00 Lung Cancer 5 2025-09-18
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination with Osimertinib as Firs… Recruiting

2024-518586-10-00 Non-Squamous Non-Small Cell Lung Cancer 10 2025-09-18
A phase 2 study of the effectiveness of golcadomide (CC-99282) for patients with large B-cell lymphoma in the brain Recruiting

2024-517051-12-00 Relapsed primary large B-cel lymphoma of the central ne 4 2025-09-16
Evaluation of efficacy and safety of GSK5764227 (alone and in combination) in participants with previously treated advanced unresectable or … Recruiting

2025-520672-26-00 Gastrointestinal Neoplasms 9 2025-09-16
Study of Daraxonrasib (RMC-6236) in Patients with RAS Mutated NSCLC Recruiting

2024-518154-16-00 non-small cell lung cancer 5 2025-08-27
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia Recruiting

2024-520154-38-00 Acute Myeloid Luekemia 5 2025-07-29
Study of Sacituzumab Govitecan Versus Standard of Care in Participants with Previously Treated Extensive Stage Small Cell Lung Cancer Recruiting

2024-515884-69-00 Extensive Stage Small Cell Lung Cancer (ES-SCLC) 5 2025-07-16
A study to evaluate the efficacy of APG-2575 (Lisaftoclax) plus azacitidine (AZA) vs. placebo plus AZA in newly diagnosed adult subjects wit… Recruiting

2024-517247-31-00 Newly Diagnosed Higher Risk Myelodysplastic Syndrome 5 2025-07-07
A Study of Nivolumab + Relatlimab Fixed-dose Combination with Chemotherapy Versus Pembrolizumab with Chemotherapy in Participants with Non-s… Recruiting

2024-513682-40-01 Non-squamous (NSQ), Stage IV or Recurrent Non-small Cel 5 2025-07-04